Endemic pemphigus foliaceus (PF), also known as Fogo Selvagem (FS), is an organ-specific autoimmune disease mediated by autoantibodies. These autoantibodies are disease specific, predominantly restricted to the IgG4 subclass, and pathogenic, as demonstrated by passive transfer studies. In contrast to pemphigus vulgaris, neonatal skin disease does not appear to occur in babies born to mothers with non-endemic PF or FS. In the present study we have examined 19 mother / neonate pairs where the mother had documented FS. Mothers and neonates were examined soon after delivery and tested by immunofluorescent (IF) techniques for FS autoantibodies either in circulation (mothers' sera or babies' cord blood) or bound to the neonatal epidermis. All neonates in-F OgO Selvagem (FS) is the endemic form of pemphigus foliaceus (PF), reported since the beginning of the century in certain. states of Brazil [1] and recently in Colombia [2] . It is thought to be precipitated by an environmental factor [1] . The disease shares similar clinical and immunopathologic features with the non-endemic form ofPF seen in the rest of the world [3] . For example, PF and FS patients possess disease-specific autoantibodies [4, 5] that are pathogenic by passive transfer studies [6] and are predominantly restricted to the IgG4 subclass [7] . Furthermore, Fab' fragments of FS IgG are also pathogenic, suggesting that the epidermal antigen(s) they recognize belong(s) to the family of cell adhesion molecules [8] . The mechanisms by which FS autoantibodies cause epidermal disease remain unknown.
Pemphigus vulgaris (PV) and PF or FS are bullous disorders with . If steroid or immunosuppressive therapy ofPV patients is delayed, the vesicles and erosions may gradually become confluent and generalized, and the mortality of these patients is high. In contrast, PF or FS are characterized by superficial epidermal vesicles and/or bullae and an absence of oral lesions. The epidermal vesicles are located beneath the stratum corneum and the antiepidermal autoantibodies recognize a desmosomal glycoprotein named desmoglein 1 (DG-1) [11] . PF and FS show a less aggressive course than PV. It is well established that female PV patients with active disease who can carry a pregnancy to term deliver babies with a transient neonatal PV [12] [13] [14] [15] [16] . Neonatal PV is presumably precipitated by the transplacental passage of pathogenic anti-epidermal autoantibodies. Contrary to this observation, it has been reported that pregnant patients with PF and FS deliver babies with normal skin [17,1 8] . Experimental data to explain these observations are not available. Therefore, the purpose of this study was to evaluate the IgG autoantibody profile in 19 FS mothers and their newborn babies. We found that all newborns from mothers with FS exhibited normal skin. Furthermore, these babies had low or no titers of autoantibodies in umbilical cord serum as compared with their mothers, who showed higher titers of serum autoantibodies. The predominant IgG subclass ofFS autoantibodies in these patients was IgG4.
MATERIALS AND METHODS
Patient Selection Nineteen FS mother/newborn pairs were included in this study. The diagnosis of FS was established in all mothers before they became pregnant by clinical, histologic, and 0022-202X/92/S 05.00 Copyright © 1992 by The Society for Investigative Dermatology, Inc.
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immunologic criteria. The diagnosis and follow-up of patients durmg pregnancy and delivery was carried out by dermatologists from endemic areas or by the leading author of this paper (Rosicler Rocha-Alvarez) . These patients were inhabitants of FS-endemic areas in the Brazilian states of Goias, Tocantins, Minas Gerais, Sao Paulo, Parana, Mato Grosso, and Brasilia.
The activity and extent of FS in mothers and neonates were scored on the day of delivery. FS was classified as previously repOrted [3] . Sixteen of 19 of the patients included in this study exhibited skin lesions typical of FS. Three patients were in complete remission induced by steroid therapy. Blood samples were collected from all mothers during delivery and from the umbilical cord of all babies. The serum was obtained by centrifugation and stored at -20°C until tested. Following appropriate consent, 3-mm punch biopsies were obtained from 17 neonates and placed in Michel's transport medium [19] . Sera were also obtained from unaffected individuals living in endemic areas and used as Controls.
Monoclonal Antibodies The isolation and extensive subclass and allotypic specificity evaluations for each monoclonal has been prevIOusly described [7, 20] . The following murine monoclonal antibodies to each of the four human IgG subclasses were utilized: HP6001 for IgGl (Calbiochem, La Jolla, CA); HP6014 for IgG2, HP6050 for IgG3, and HP6025 for IgG4 (Miles Scientific, Naperville, IL). Each of the four monoclonals was obtained as an ascite preparation and used at a dilution of 1 : 5000.
Itntnunofluorescence Techniques Indirect immunofluorescence (IF) techniques were performed using human skin cryosectlons as previously described [21, 22] . The bound IgG subclass autoantibodies were detected using murine monoclonal antihuman Ig. G-subclass-specific antibodies (see above) . Final incubation was With a sheep fluorescein isothiocynate (FITC)-conjugated antirnouse IgG (Cappel, West Chester, PA) . The sections were examIned With a Nikon epifluorescent microscope . Each of the sera was titrated to the endpoint for each IgG subclass.
Direct IF studies were performed using cryosections of skin from neonates and mothers. A minimum of three sections were incubated with IgG-subclass _ specific mouse antihuman monoclonal antibod-T (1: 5000). The bound monoclonal antibody was detected by ~:ee~ FITC-conjugated anti mouse IgG serum. The intensity of the action was scored from -to +++. The distribution ofFS autoantibody activity in each IgG subclass in the sera of mothers and neonates are also presented in Tables I -IV. In 10 of 19 babies' cord sera, there was no FS autoantibody activity; in six babies the titer of IgG4 autoantibodies was 1: 10 (babies 1, 3, 5, 11, 14, and 18); in two the titers were 1 : 20 (babies 2 and 13); and in one the titer was 1: 40 (baby 7). In three mothers with elevated titers ofIgG4 FS autoantibodies, there were low titers of IgG 1 and IgG2 autoantibodies (mothers of pairs 3, 6, and 11); however, these antibodies were not detected in the babies' cord serum.
Control sera (over 500) from donors living in endemic and nonendemic areas of FS showed negative results by indirect IF techniques using human skin substrate and FITC-antihuman IgG or monoclonal antibodies against human IgG subclasses.
DISCUSSION
The normal development of a fetus during pregnancy in an immunocompetent mother represents one of the mysteries of immunology. The maternal immune system appears to passively or actively ignore the presence of the developing fetus except in a few occasions when the mother becomes sensitized to fetal antigens. In these rare instances the mother produces pathogenic antibodies that may reach the fetus and cause disease, e.g., Rh or ABO hemolytic disease of the newborn [23] and neonatal alloimmune thrombocytopenia [24] . In physiologic states, transplacental passage of maternal antibacterial and antiviral antibodies to the fetus will protect the newborn against undesirable infections during the first few months of life [25] .
The passive transfers of tissue-specific autoantibodies to experimental animals have reproduced the respective organ-specific disease in myasthenia gravis [26] , PV [9], endemic PF or FS [6-8], and Goodpasture's syndrome [27] . These experimental animal models strongly support the pathogenic role of these autoantibodies in mediating the respective human disease.
Pregnant women suffering autoimlJlune disease have been reported to deliver babies with a spectrum of clinical syndromes due to the transplacental passage of pathogenic autoantibodies. These syndromes constitute "experiments of nature" of passive transfer experiments carried out in laboratory animals. For example, mothers with SLE having Ro autoantibodies in their sera have delivered babies with neonatal lupus [28] . Neonatal lupus is characterized by cutaneous lesions and frequent cardiac conduction defects, which are thought to be produced by maternal Ro autoantibodies that have reached the fetal circulation and target tissues (29] . Similarly, herpes gestationis (HG) is a cutaneous autoimmune disease that occurs in the last trimester of pregnancy and has been associated, on a few occasions, with a transient skin eruption in the newborn [30] and HG factor in cord serum [31] .
On the contrary, babies born to mothers with well documented PV or myasthenia gravis or autoimmune thyroid disease are likely to develop either neonatal PV (12) (13) (14) (15) (16) , neonatal myasthenia gravis [32] [33] [34] [35] [36] [37] , or signs of neonatal thyroid dysfunction [38, 39] . It has been postulated that maternal autoantibodies may reach the babies' circulation and cause transient disease in the epidermis, the muscle, or the thyroid gland, respectively. In PV, the correlation of autoantibody titers and disease activity in the mother and the newborn appear to correlate fairly well. This correlation is not seen in myasthenia gravis, where only 12% of the newborns may show clinical [32) . For example, mothers could have active muscle disease and high titers of anti-acetylcholine receptor autoantibodies and deliver normal babies [34) . It has been postulated that other factors, i.e., alpha-fetoprotein [33) or thymus [35) , may modulate the expression of neonatal myasthenia gravis. In autoimmune thyroid diseases, maternal autoantibodies may cause hyper-or hypothyroidism [38, 39) .
In the present study of 19 mother/neonate pairs, in whom the mother had well documented FS, all babies were born with clinically normal skin. These findings confirm the results published by Proenca et al [17) . One baby was born with Down's syndrome and multiple congenital abnormalities and died on the second day oflife. The mother of this neonate was 48 years of age and had FS for several years. Two FS mothers carried two pregnancies to term, delivering healthy newborns (pairs 5 and 15, and 8 and 14). The results of this investigation show that maternal autoantibodies of the IgG4 subclass were predominant in the sera of mothers with FS . These findings duplicate our early studies [7). The majority of neonates did not show FS autoantibodies in their cord sera (10/19) or bound to their skin (12/17). In the 9 cases where the baby's cord sera showed a low titer of FS autoantibodies, there was no correlatiOn between this finding and weakly positive direct IF of neonatal skin. The absence of clinical disease in the majority of newborns could be due to either the absence, or negligible titers, of FS autoantibodies in the fetal circulation, which are known to be pathogenic [6 -S), or the lack of reactive antigens on the fetal epidermis. The second possibility seems to be unlikely, as it is known that neonatal epidermis contains FS antigens, as shown by indirect IF studies in several publications [6 -8,21,22) . Moreover, the epidermis of five neonates showed weak epidermal ICS staining by direct IF, four of whom also exhibited low titers « 1 : 20) of FS autoantibodies in the cord serum (babies 1,2, 3, and 11), suggesting that the neonate epidermis expressed the FS antigens.
It is possible that the placenta may have limited the passage ofFS autoantibodies to the baby by its barrier function [40) . Maternal immunoglobulins of the IgG class cross the placenta and reach the fetal circulation through an active Fe-receptor transport mechanism [41) . This transport varies according to the IgG subclass involved, i.e., IgGI > IgG2 > IgG4 > IgG3 [42) and appears to be regulated also by the functional activity of the antibodies, i.e., avidity [43) . Other transport mechanisms have been described in the placenta that may regulate the passage of charged protein molecules [44] . This may apply to the passage of autoantibodies of unique isoelectric pOint. There is no transplacental passage ofIgM, IgA, IgD, and IgE UUmunoglobulins from the mother to the fetus [45] .
It is also possible that the placenta may function as an immunoadhorbent of undesirable antibodies, as suggested by Swinburne [46] . It as been shown that placenta contains desmosomal organelles [47] ; however, it is unknown at present if they contain immunoreactive DG-l. Those FS autoantibodies that overflow the "placental immunoadsorbent" may reach the fetal circulation. Once these lowlter autoantibodies diffuse out of the circulation they will be readily Ound by the neonate squamous epithelial tissues and produce a weak positive staining of the epidermal ICS by direct IF. Our studies would suggest that in FS the placenta appears to playa crucial role in mo~ulating the expression of disease in the neonate. F Finally, this study also suggests that the etiologic agent triggering . S, If I11fectious, does not appear to harm the neonate. Further work IS needed to document the incidence of FS in children born to mothers with active disease. HLA haplotypes of the family and exposure to risk factors will be extremely important in these future s~udies. HLA studies in FS show that patients carry a susceptibility to t e DR1 Dw20 gene and lack a protective DQw2 gene, present in nor~al relatives [48] . Further, a recent case-control study carried ~Ut 111 the Hospital do Penfi.go in Goiania (state of Goias, Brazil) emonstrates that exposure to black fly bites causes a fourfold in-'~rease in the chance of developing FS in farmers exposed to this risk [actor [49] . 
